These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 3105541)
1. The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the hepatotoxicity, of carbon tetrachloride in mice. Labbe G; Descatoire V; Letteron P; Degott C; Tinel M; Larrey D; Carrion-Pavlov Y; Geneve J; Amouyal G; Pessayre D Biochem Pharmacol; 1987 Mar; 36(6):907-14. PubMed ID: 3105541 [TBL] [Abstract][Full Text] [Related]
2. Methoxsalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in mice. Lettéron P; Degott C; Labbe G; Larrey D; Descatoire V; Tinel M; Pessayre D Toxicol Appl Pharmacol; 1987 Nov; 91(2):266-73. PubMed ID: 3118512 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of cytochrome P-450 by the drug methoxsalen. Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395 [TBL] [Abstract][Full Text] [Related]
4. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice. Letteron P; Descatoire V; Larrey D; DeGott C; Tinel M; Geneve J; Pessayre D J Pharmacol Exp Ther; 1986 Nov; 239(2):559-67. PubMed ID: 3772810 [TBL] [Abstract][Full Text] [Related]
5. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety. Labbe G; Descatoire V; Beaune P; Letteron P; Larrey D; Pessayre D J Pharmacol Exp Ther; 1989 Sep; 250(3):1034-42. PubMed ID: 2506333 [TBL] [Abstract][Full Text] [Related]
6. Protection against carbon tetrachloride hepatotoxicity by 5,10-dihydroindeno[1,2-b]indole, a potent inhibitor of lipid peroxidation. Shertzer HG; Sainsbury M Food Chem Toxicol; 1988 Jun; 26(6):517-22. PubMed ID: 3169651 [TBL] [Abstract][Full Text] [Related]
7. Endotoxin pretreatment protects against the hepatotoxicity of acetaminophen and carbon tetrachloride: role of cytochrome P450 suppression. Liu J; Sendelbach LE; Parkinson A; Klaassen CD Toxicology; 2000 Jul; 147(3):167-76. PubMed ID: 10924799 [TBL] [Abstract][Full Text] [Related]
8. The effect of the administration of cobaltic protoporphyrin IX on drug metabolism, carbon tetrachloride activation and lipid peroxidation in rat liver microsomes. Cheeseman KH; Albano EF; Tomasi A; Slater TF Chem Biol Interact; 1984 Jul; 50(2):143-51. PubMed ID: 6430572 [TBL] [Abstract][Full Text] [Related]
9. Effects of methoxsalen on the metabolism of acetaminophen in humans. Amouyal G; Larrey D; Letteron P; Geneve J; Labbe G; Belghiti J; Pessayre D Biochem Pharmacol; 1987 Jul; 36(14):2349-52. PubMed ID: 3606645 [TBL] [Abstract][Full Text] [Related]
10. Reduced glutathione protection against rat liver microsomal injury by carbon tetrachloride. Dependence on O2. Burk RF; Patel K; Lane JM Biochem J; 1983 Dec; 215(3):441-5. PubMed ID: 6318726 [TBL] [Abstract][Full Text] [Related]
11. Carbon tetrachloride-induced liver injury in the rabbit. Bernacchi AS; de Castro CR; de Ferreyra EC; Villarruel MC; Fernández G; de Fenos OM; Castro JA Br J Exp Pathol; 1983 Jun; 64(3):261-7. PubMed ID: 6309207 [TBL] [Abstract][Full Text] [Related]
12. Evidence for carbon tetrachloride-induced lipid peroxidation in mouse liver. Lee PY; McCay PB; Hornbrook KR Biochem Pharmacol; 1982 Feb; 31(3):405-9. PubMed ID: 7073767 [TBL] [Abstract][Full Text] [Related]
13. Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Lettéron P; Labbe G; Degott C; Berson A; Fromenty B; Delaforge M; Larrey D; Pessayre D Biochem Pharmacol; 1990 Jun; 39(12):2027-34. PubMed ID: 2353942 [TBL] [Abstract][Full Text] [Related]
14. Protection of hepatocytes with hyperoxia against carbon tetrachloride-induced injury. Bernacchi A; Myers R; Trump BF; Marzella L Toxicol Pathol; 1984; 12(4):315-23. PubMed ID: 6533753 [TBL] [Abstract][Full Text] [Related]
15. Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives. Tinel M; Belghiti J; Descatoire V; Amouyal G; Letteron P; Geneve J; Larrey D; Pessayre D Biochem Pharmacol; 1987 Mar; 36(6):951-5. PubMed ID: 3494453 [TBL] [Abstract][Full Text] [Related]
16. Effect of hypoxia on carbon tetrachloride hepatotoxicity. Shen ES; Garry VF; Anders MW Biochem Pharmacol; 1982 Dec; 31(23):3787-93. PubMed ID: 7159461 [TBL] [Abstract][Full Text] [Related]
17. Modification of carbon tetrachloride hepatotoxicity by chemicals. Suriyachan D; Thithapandha A Toxicol Appl Pharmacol; 1977 Aug; 41(2):369-76. PubMed ID: 408944 [No Abstract] [Full Text] [Related]
18. Studies on the mechanism of glutathione prevention of carbon tetrachloride-induced liver injury. Gorla N; de Ferreyra EC; Villarruel MC; de Fenos OM; Castro JA Br J Exp Pathol; 1983 Aug; 64(4):388-95. PubMed ID: 6615708 [TBL] [Abstract][Full Text] [Related]
19. Activation of carbon tetrachloride, and distribution of NADPH-cytochrome c reductase, cytochrome P-450, and other microsomal enzyme activities in rat tissues. Benedetto C; Dianzani MU; Ahmed M; Cheeseman K; Connelly C; Slater TF Biochim Biophys Acta; 1981 Nov; 677(3-4):363-72. PubMed ID: 6794650 [No Abstract] [Full Text] [Related]
20. Dichloromethane potentiation of carbon tetrachloride hepatotoxicity in rats. Kim YC Fundam Appl Toxicol; 1997 Jan; 35(1):138-41. PubMed ID: 9024681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]